Announcements Trials

Browse Landscape

Phase

Phase NA 2 Phase 2 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1 Gastrointestinal 1 Breast 1

Conditions

Breast Neoplasms 2760 Triple Negative Breast Neoplasms 404 Neoplasm Metastasis 155 Breast Neoplasms, Male 102 Neoplasms 99 Ovarian Neoplasms 68 Carcinoma, Intraductal, Noninfiltrating 68 Carcinoma, Non-Small-Cell Lung 67 Lung Neoplasms 66 Brain Neoplasms 60 Inflammatory Breast Neoplasms 50 Colorectal Neoplasms 49 Breast Carcinoma In Situ 47 Advanced Breast Cancer 47 Prostatic Neoplasms 41 Melanoma 38 Pancreatic Neoplasms 37 Stomach Neoplasms 32 Uterine Cervical Neoplasms 27 Sarcoma 27 HER2-positive Breast Cancer 27 Endometrial Neoplasms 25 Head and Neck Neoplasms 24 Recurrence 23 Colonic Neoplasms 22 Carcinoma, Renal Cell 21 Carcinoma, Ovarian Epithelial 21 Multiple Myeloma 20 Carcinoma, Ductal, Breast 20 Small Cell Lung Carcinoma 19

Interventions

Zoledronic Acid 1 Neoadjuvant Therapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Neovascularization, Pathologic × Breast × Clear all

NCT01367288 2019-05-28

NEOZOL

Hospices Civils de Lyon

Phase 2 Completed

Breast Neoplasms, Neovascularization, Pathologic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡